ImmunoGen immunogen.com


ImmunoGen (IMGN) is a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer.

ImmunoGen (IMGN) is a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer.

Company (IPO / Went public)

Phone: 781-895-0600

Fax:

830 Winter Street

Waltham, 02451
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImmunoGen $0M Apr 15, 2021

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImmunoGen Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of preparing indolinobenzodiazepine derivatives Sep 04, 2019 Apr 06, 2021 Patent
Novel benzodiazepine derivatives Dec 21, 2018 Mar 16, 2021 Patent
Methods for the acylation of maytansinol Sep 18, 2019 Mar 09, 2021 Patent
Anti-cd123 antibodies and conjugates and derivatives thereof Aug 03, 2017 Feb 16, 2021 Patent
Methods of preparing cytotoxic benzodiazepine derivatives Nov 11, 2019 Feb 09, 2021 Patent
See all 252 patents